SuperworthTenet Healthcare THC
- Market cap
- $21.6B
- PE
- 10.4×
- 8y median 11.2×
- Forward PE
- 12.9×
- 10y median 12.8×
- Price to sales
- 1.0×
- EV/EBIT
- 7.5×
- Revenue, 12 months
- $21.8B
- +5% on a year ago
- Net margin
- 10.3%
- Free cash flow yield
- 14.0%
Tenet Healthcare trades at 10.4× trailing earnings, near its ten-year median. Revenue was $21.8B over the last twelve months, up 5% on a year earlier with a 10% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $5.1B+6% | $5.4B+8% | $5.4B+7% | $5.1B+1% | $5.1B+1% | $5.1B−6% | $5.2B−3% | $5.3B+3% | $5.3B+3% | $5.5B+9% | $5.4B+3% | $5.6B+7% | |
| $568M−5% | $735M+37% | $3.3B+445% | $761M+26% | $1.1B+92% | $821M+12% | $943M−71% | $823M+8% | $889M−18% | $853M+4% | $1.3B+37% | $1.5B+82% | |
| Interest expense | $227M+2% | $227M+4% | $218M−1% | $203M−10% | $202M−11% | $203M−11% | $204M−6% | $206M+2% | $206M+2% | $205M+1% | $205M+1% | $204M−1% |
| Pre-tax income | $345M−9% | $519M+62% | $3.1B+712% | $587M+57% | $922M+167% | $655M+26% | $765M−75% | $642M+9% | $712M−23% | $681M+4% | $1.1B+48% | $1.3B+109% |
| $79M−30% | $63M+34% | $750M+793% | $110M+38% | $241M+205% | $83M+32% | $143M−81% | $120M+9% | $133M−45% | $37M−55% | $226M+58% | $295M+146% | |
| Net income | $101M−23% | $244M+139% | $2.2B+1404% | $259M+111% | $472M+367% | $318M+30% | $406M−81% | $288M+11% | $342M−28% | $371M+17% | $702M+73% | $826M+187% |
| $0.94−19% | $2.34+141% | $21.38+1520% | $2.64+130% | $4.89+420% | $3.31+42% | $4.27−80% | $3.14+19% | $3.86−21% | $4.22+28% | $8.01+88% | $9.84+213% | |
| 104.4M−5% | 104.1M−1% | 100.6M−5% | 98.4M−6% | 96.7M−7% | 96M−8% | 95M−6% | 91.8M−7% | 88.6M−8% | 87.9M−8% | 87.6M−8% | 84M−9% |
EPS, diluted: 15 periods, Q4 FY09 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 9 periods, Q4 FY09 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. 6 periods, Q4 FY11 to Q4 FY18: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY14 and Q4 FY20: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $5.5B | $5.4B to $5.5B | $4.68 | $4.10 to $5.19 | 13 |
| Q4 FY26 | $5.7B | $5.7B to $5.8B | $5.67 | $5.12 to $6.70 | 13 |
| Q1 FY27 | $5.4B | $5.4B to $5.7B | $4.93 | $4.86 to $5.18 | 5 |
| Q2 FY27 | $5.6B | $5.6B to $5.9B | $5.57 | $5.49 to $5.86 | 5 |
| Q3 FY27 | $5.6B | $5.5B to $5.8B | $4.90 | $4.83 to $5.15 | 5 |
| Q4 FY27 | $5.8B | $5.8B to $6.1B | $5.89 | $5.80 to $6.19 | 5 |
| Q1 FY28 | $5.7B | $5.6B to $5.9B | $5.10 | $5.03 to $5.36 | 6 |
| Q2 FY28 | $5.9B | $5.8B to $6.1B | $5.78 | $5.69 to $6.08 | 6 |
Peers
Companies in Medical - Care Facilities nearest Tenet Healthcare's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| THCTenet Healthcare | $21.6B | 10.4× | 11.2× | 12.9× | 1.0× | +5% | 10.3% |
| EHCEncompass Health | $12.2B | 20.2× | 18.4× | n/m | 2.0× | +9% | 10.0% |
| BTSGBrightSpring Health Services | $11.9B | 36.4× | 57.7× | n/m | 0.8× | +26% | 2.5% |
| DVADavita | $11.7B | 15.0× | 16.1× | n/m | 0.8× | +6% | 6.0% |
| UHSUniversal Health Services | $11B | 7.6× | 13.6× | n/m | 0.6× | +10% | 8.4% |
| ENSGEnsign | $10.2B | 27.5× | 25.5× | n/m | 1.9× | +19% | 6.9% |
| PACSPACS | $7.5B | 27.2× | 27.2× | n/m | 1.4× | +15% | 4.8% |
| CHEChemed | $6.7B | 25.8× | 29.0× | n/m | 2.6× | +3% | 10.6% |
| SHCSotera Health | $5.2B | 31.8× | 55.4× | n/m | 4.2× | +8% | 13.4% |
| CONConcentra Group Holdings Parent | $5B | 25.5× | 17.5× | n/m | 2.2× | +14% | 8.7% |
| LFSTLifeStance Health | $4.9B | 99.5× | 142× | n/m | 3.1× | +20% | 3.2% |
| Peer median | $8.9B | 26.5× | 26.3× | n/a | 1.9× | +12% | 7.7% |
Investors who own it
Investors we follow who held Tenet Healthcare at the end of Jun 30, 2026, from their 13F filings.
- Bill NygrenHarris Associates (Oakmark)0.0% of portfolio
More on Tenet Healthcare
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #9of 168Healthcare stocks with the lowest PE ratio
- #2of 25Hospital and care facility stocks with the lowest PE ratio
- #3of 32Hospital and care facility stocks with the highest free cash flow yield
- #3of 31Hospital and care facility stocks with the lowest EV/EBIT
- #6of 51Healthcare stocks with the lowest forward PE
- #6of 42Hospital and care facility stocks with the highest profit margins
- #4of 21Hospital and care facility stocks with the fastest earnings growth
Its groups
About
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .